Search research articles
Contact Us
Filters
Showing results (351-360 of 432) with videos related to
Page
of 44
Sort By:
Cephalalgia : an International Journal of Headache
|
October 27, 2010
Randomized, controlled trial of telcagepant over four migraine attacks
Andrew P Ho, Carl Gh Dahlöf, Stephen D Silberstein, et al.
The Lancet. Neurology
|
May 22, 2021
Post-traumatic headache attributed to traumatic brain injury: classification, clinical characteristics, and treatment
Håkan Ashina, Anna K Eigenbrodt, Tad Seifert, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 9, 2015
Morphological Abnormalities of Thalamic Subnuclei in Migraine: A Multicenter MRI Study at 3 Tesla
Stefano Magon, Arne May, Anne Stankewitz, et al.
Cephalalgia : an International Journal of Headache
|
June 1, 2019
Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine
Messoud Ashina, Peter J Goadsby, Uwe Reuter, et al.
The Lancet. Neurology
|
April 13, 2013
Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study
Faisal Mohammad Amin, Mohammad Sohail Asghar, Anders Hougaard, et al.
JAMA Dermatology
|
April 17, 2024
Erenumab for Treatment of Persistent Erythema and Flushing in Rosacea: A Nonrandomized Controlled Trial
Nita K F Wienholtz, Casper E Christensen, Thien P Do, et al.
Neurology
|
April 17, 2024
Differences in Cortical Morphology in People With and Without Migraine: A Registry for Migraine (REFORM) MRI Study
Rune H Christensen, Håkan Ashina, Haidar M Al-Khazali, et al.
Cephalalgia : an International Journal of Headache
|
December 2, 2023
Placebo and nocebo in the treatment of migraine: How much does real world effectiveness depend on contextual effects?
Hauke Basedau, Raffaele Ornello, Eleonora De Matteis, et al.
Headache
|
June 14, 2023
Long-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis
Stewart J Tepper, Richard B Lipton, Stephen D Silberstein, et al.
The Journal of Headache and Pain
|
June 2, 2022
Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study
Christopher Kjaer Cullum, Thien Phu Do, Messoud Ashina, et al.
Page
of 44
Search research articles
Search
Showing results (351-360 of 432) with videos related to
Sort By:
Page
of 44
Cephalalgia : an International Journal of Headache
|
October 27, 2010
Randomized, controlled trial of telcagepant over four migraine attacks
Andrew P Ho, Carl Gh Dahlöf, Stephen D Silberstein, et al.
The Lancet. Neurology
|
May 22, 2021
Post-traumatic headache attributed to traumatic brain injury: classification, clinical characteristics, and treatment
Håkan Ashina, Anna K Eigenbrodt, Tad Seifert, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 9, 2015
Morphological Abnormalities of Thalamic Subnuclei in Migraine: A Multicenter MRI Study at 3 Tesla
Stefano Magon, Arne May, Anne Stankewitz, et al.
Cephalalgia : an International Journal of Headache
|
June 1, 2019
Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine
Messoud Ashina, Peter J Goadsby, Uwe Reuter, et al.
The Lancet. Neurology
|
April 13, 2013
Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study
Faisal Mohammad Amin, Mohammad Sohail Asghar, Anders Hougaard, et al.
JAMA Dermatology
|
April 17, 2024
Erenumab for Treatment of Persistent Erythema and Flushing in Rosacea: A Nonrandomized Controlled Trial
Nita K F Wienholtz, Casper E Christensen, Thien P Do, et al.
Neurology
|
April 17, 2024
Differences in Cortical Morphology in People With and Without Migraine: A Registry for Migraine (REFORM) MRI Study
Rune H Christensen, Håkan Ashina, Haidar M Al-Khazali, et al.
Cephalalgia : an International Journal of Headache
|
December 2, 2023
Placebo and nocebo in the treatment of migraine: How much does real world effectiveness depend on contextual effects?
Hauke Basedau, Raffaele Ornello, Eleonora De Matteis, et al.
Headache
|
June 14, 2023
Long-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis
Stewart J Tepper, Richard B Lipton, Stephen D Silberstein, et al.
The Journal of Headache and Pain
|
June 2, 2022
Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study
Christopher Kjaer Cullum, Thien Phu Do, Messoud Ashina, et al.
Page
of 44